Delayed presentation of pembrolizumab-induced SJS-TEN overlap syndrome [0.03%]
迟发性派姆单抗诱导的中毒性表皮坏死松解症-史蒂文斯-约翰逊综合征重叠综合征病例
Drew A Wells,Gabriela Acton,Zachery Halford
Drew A Wells
Introduction: Immune checkpoint inhibitors (ICIs), such as pembrolizumab, are integral to cancer therapy but can cause severe immune-related adverse events (irAEs), including Stevens-Johnson syndrome (SJS) and toxic epide...
Effects of fluconazole and voriconazole on cyclosporine levels and toxicity in allogenic hematopoietic stem cell transplant recipients: A comprehensive analysis [0.03%]
氟康唑和伏立康唑对allo-HSCT受者环孢素浓度及毒性的影响：全面分析
Aisha Rafiq,Waseem Shahani,Shafaq Samad et al.
Aisha Rafiq et al.
ObjectiveHematopoietic stem cell transplant (HSCT) is the only curative option for genetic, immunological, and hematological disorders such as leukemia, lymphoma, and bone marrow failure syndromes. Graft-versus-host disease (GVHD) remains t...
Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis [0.03%]
乳腺癌患者紫杉烷类化疗相关外周神经病发生率的网络meta分析
Samineh Beheshtirouy,Zeinab Nikniaz,Saba Ghaffary et al.
Samineh Beheshtirouy et al.
IntroductionTaxane-induced peripheral neuropathy (TIPN) is a common toxicity among patients with breast cancer (BC). Numerous pairwise comparisons have been performed to evaluate neuropathy associated with different taxane agents (docetaxel...
Concern regarding "A novel decision tree for performing risk assessments of biologics in a health-system setting" [0.03%]
关于生物制品健康体系风险评估的新决策树的担忧
Melissa McDiarmid,Thomas Connor,Patricia Kienle et al.
Melissa McDiarmid et al.
Safety evaluation of outpatient ifosfamide regimens in adult sarcoma patients [0.03%]
成人恶性肿瘤日间医疗异环磷酰胺方案的安全性分析
Kevin K Cheng,Vanessa Copeland,Angel Liu et al.
Kevin K Cheng et al.
Introduction: Transitioning historically inpatient chemotherapy regimens to outpatient administration can reduce hospital stays, resource use, and healthcare expenditures while improving patient quality of life. However, ...
Response to letter to the editor: A novel decision tree for performing risk assessments of biologics in a health-system setting [0.03%]
致编辑部的信的回应：在医疗系统环境下对生物制剂进行风险评估的新决策树模型
Zoe Ngo,Scott Mayeda,Stacey Yu et al.
Zoe Ngo et al.
Revisiting predictors of high-dose methotrexate related severe nephrotoxicity in children with acute lymphoblastic leukemia [0.03%]
儿童急性淋巴细胞白血病高剂量化疗致重度肾毒性的预测因素研究
Chane Choed-Amphai,Jiraporn Khorana,Lalita Sathitsamitphong et al.
Chane Choed-Amphai et al.
IntroductionAcute lymphoblastic leukemia (ALL) is the most common childhood cancer, and high-dose methotrexate (HDMTX) is a key chemotherapeutic agent. HDMTX can cause nephrotoxicity. This study aimed to identify prognostic indicators of HD...
Chamomile mouthwash for prevention of chemotherapy-induced oral mucositis: A prospective cohort study in a pharmacist-led supportive care setting [0.03%]
茶树口含液预防化疗引起的口腔黏膜炎：药师支持治疗环境下的前瞻性队列研究
Imane Benmoussa,Salma Rokki,Samira Hassoune et al.
Imane Benmoussa et al.
Chemotherapy-induced oral mucositis (OM) is a common and distressing complication of cancer treatment, significantly impacting patients' quality of life. Chamomile (Matricaria recutita L.), known for its anti-inflammatory and wound-healing ...
Comparing relative dose intensity of weekly nab-paclitaxel regimens in early breast cancer: A retrospective study at a large academic outpatient cancer center [0.03%]
早期乳腺癌每周纳米白蛋白结合型紫杉醇方案相对剂量强度的比较：大型学术性门诊肿瘤中心的回顾性研究
Kendra Gee-Rodriguez,Jina Yun,Arianne Duong et al.
Kendra Gee-Rodriguez et al.
IntroductionNational guidelines for breast cancer support substitution with nab-paclitaxel for paclitaxel or docetaxel due to medical necessity.1 This study aimed to assess for correlation between weekly nab-paclitaxel dose and relative dos...
The impact of growth factor utilization on infection risk in patients receiving bispecific monoclonal antibodies [0.03%]
生长因子使用对接受双特异性单克隆抗体治疗患者的感染风险的影响
Yong Jun Bae,Houry Leblebjian,Robert Redd et al.
Yong Jun Bae et al.
BackgroundBispecific monoclonal antibodies (BsAbs) are utilized in patients with relapsed or refractory multiple myeloma (MM) and light chain amyloidosis (AL amyloidosis) but are associated with high rates of neutropenia and infection. Gran...